Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| R1 RCM Inc. /DE | 164,754,055 | reported | 13 Sept 2022 | tx 1−15,000,000 |
| Accretive Health, Inc. | 139,289,200 | reported | 01 Jun 2021 | tx 6+16,922,512−33,825,292 |
| J.Jill, Inc. | 26,381,136 | reported | 25 Jun 2019 | tx 4+262,849−865,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Sept 2022 | SALE | R1 RCM Inc. /DE | 15,000,000 | 20.43 USD | |
| 27 May 2021 | SALE | Accretive Health, Inc. | 2,412,646 | 24.54 USD | |
| 01 Jun 2021 | SALE | Accretive Health, Inc. | 14,500,000 | 21.83 USD | |
| 27 May 2021 | EXERCISE | Accretive Health, Inc. | 16,912,646 | 3.50 USD | |
| 27 May 2021 | EXERCISE | Accretive Health, Inc. | 16,912,646 | 0.00 USD | deriv |
| 01 Oct 2019 | GRANT_AWARD | Accretive Health, Inc. | 5,226 | — | deriv |
| 24 Jun 2019 | PURCHASE | J.Jill, Inc. | 84,965 | 1.67 USD | |
| 25 Jun 2019 | PURCHASE | J.Jill, Inc. | 57,100 | 1.68 USD | |
| 18 Jun 2019 | PURCHASE | J.Jill, Inc. | 120,784 | 1.65 USD | |
| 02 Apr 2018 | GRANT_AWARD | Accretive Health, Inc. | 4,640 | — | deriv |
| 04 Apr 2017 | SALE | J.Jill, Inc. | 865,000 | 12.09 USD |